ZENITH | A clinical study for people with peanut allergy

Developing, funding and conducting clinical trials in immune tolerance

The ZENITH study may be an option

for people 12 to 55 years old who are

allergic to peanut.

The ZENITH Study

A clinical trial testing whether peanut oral immunotherapy in combination with an experimental medication will lower the risk of life threatening allergic reactions in people allergic to peanut.

Learn more ›

Am I Eligible?

If you are 12-55 and have peanut allergy, you may be eligible for ZENITH.

Learn more ›

Study Locations

ZENITH is enrolling participants at clinical research study sites across the United States.

Learn more ›